Quantitative analysis of HER2-mediated effects on HER2 and epidermal growth factor receptor endocytosis - Distribution of homo- and heterodimers depends on relative HER2 levels

被引:145
作者
Hendriks, BS
Opresko, LK
Wiley, HS
Lauffenburger, D [1 ]
机构
[1] MIT, Dept Chem Engn, Cambridge, MA 02139 USA
[2] MIT, Dept Biol, Biol Engn Div, Cambridge, MA 02139 USA
[3] MIT, Ctr Canc Res, Cambridge, MA 02139 USA
[4] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA
关键词
D O I
10.1074/jbc.M300477200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endocytic trafficking plays an important role in the regulation of the epidermal growth factor receptor ( EGFR) family. Many cell types express multiple EGFR family members (including EGFR, HER2, HER3, and/or HER4) that interact to form an array of homo- and heterodimers. Differential trafficking of these receptors should strongly affect signaling through this system by changing substrate access and heterodimerization efficiency. Because of the complexity of these dynamic processes, we used a quantitative and computational model to understand their integrated operation. Parameters characterizing EGFR and HER2 interactions were determined using experimental data obtained from mammary epithelial cells constructed to express different levels of HER2, enabling us to estimate receptor-specific internalization rate constants and dimer uncoupling rate constants. Significant novel results obtained from this work are as follows: first, that EGFR homodimerization and EGFR/HER2 heterodimerization occur with comparable affinities; second, that EGFR/HER2 heterodimers traffic as single entities. Furthermore, model predictions of the relationship of HER2 expression levels to consequent distribution of EGFR homodimers and EGFR/HER2 heterodimers suggest that the levels of HER2 found on normal cells are barely at the threshold necessary to drive efficient heterodimerization. Thus, altering HER2 concentrations, either overall or local, could provide an effective mechanism for regulating EGFR/HER2 heterodimerization and may explain why HER2 overexpression found in some cancers has such a profound effect on cell physiology.
引用
收藏
页码:23343 / 23351
页数:9
相关论文
共 56 条
[1]   The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions [J].
Alroy, I ;
Yarden, Y .
FEBS LETTERS, 1997, 410 (01) :83-86
[2]  
Baulida J, 1996, J BIOL CHEM, V271, P5251
[3]   Epidermal growth factor receptor dimerization monitored in live cells [J].
Blakely, BT ;
Rossi, FMV ;
Tillotson, B ;
Palmer, M ;
Estelles, A ;
Blau, HM .
NATURE BIOTECHNOLOGY, 2000, 18 (02) :218-222
[4]   c-erbB-2/EGFR as dominant heterodimerization partners determine a motogenic phenotype in human breast cancer cells [J].
Brandt, BH ;
Roetger, A ;
Dittmar, T ;
Nikolai, G ;
Seeling, M ;
Merschjann, A ;
Nofer, JR ;
Dehmer-Möller, G ;
Junker, R ;
Assmann, G ;
Zaenker, KS .
FASEB JOURNAL, 1999, 13 (14) :1939-1949
[5]  
Burke PM, 1999, J CELL PHYSIOL, V180, P448, DOI 10.1002/(SICI)1097-4652(199909)180:3<448::AID-JCP16>3.0.CO
[6]  
2-8
[7]  
Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO
[8]  
2-T
[9]   ERBB-2 IS A POTENT ONCOGENE WHEN OVEREXPRESSED IN NIH/3T3 CELLS [J].
DIFIORE, PP ;
PIERCE, JH ;
KRAUS, MH ;
SEGATTO, O ;
KING, CR ;
AARONSON, SA .
SCIENCE, 1987, 237 (4811) :178-182
[10]   DOWN-MODULATION OF AN ONCOGENE PROTEIN PRODUCT AND REVERSION OF THE TRANSFORMED PHENOTYPE BY MONOCLONAL-ANTIBODIES [J].
DREBIN, JA ;
LINK, VC ;
STERN, DF ;
WEINBERG, RA ;
GREENE, MI .
CELL, 1985, 41 (03) :695-706